According to the latest research by Persistence Market Research, the pharyngeal manometry testing market is set to witness 6.5% growth during 2021-2031. The global pharyngeal manometry testing market is expected to be driven by the rising prevalence of dysphagia, increase in number of patients with diffuse esophageal spasm, scleroderma, and achalasia.
According to the National Center for Biotechnology Information (NCBI), the prevalence of dysphagia in the general population is estimated around 20%, and it is estimated to affect up to 50% to 66% of people over 60 years of age.
Older populations, patients with a history of stroke, alzheimer’s disease, or amyotrophic lateral sclerosis are more likely to report dysphagia. In younger populations, dysphagia is often associated with an underlying systemic illness, such as autoimmune diseases, gastroesophageal reflux disease (GERD), or eosinophilic esophagitis.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32912
Ringing number of patients with gastroesophageal reflux disease (GERD), changing dietary habits, rise in geriatric population, advanced healthcare facilities, increasing healthcare awareness, growing surgical procedures number, growing demand for minimally invasive surgeries, and raising R&D activities are the major factors uplifting the growth of the global pharyngeal manometry testing market.
According to World Gastroenterology Organization, there are reported differences in the prevalence of gastroesophageal reflux disease, ranging from 2.5% to 6.6% in Asia up to 13.8% to 25.8% in North America.. The presence of significant market players working on the development and introduction of unique and revolutionary pharyngeal manometry testing device is fueling market demand even more.
The market for pharyngeal manometry testing market is most prominently driven by countries like US and Canada. The increasing prevalence of gastrointestinal diseases, favorable reimbursement policies, the aging population, presence of major market players are the major factors that are boosting the growth of the esophageal catheters market results in an increasing demand for pharyngeal manometry testing in the US and Canada.
The US and Canada are undertaking a variety of attempts to strengthen their research and development facilities to produce technologically advanced pharyngeal manometry testing devices.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
Europe is one of the leading market in pharyngeal manometry testing market due to well-established health care infrastructure, growing number of surgical procedures and growing demand for minimally invasive surgeries to dominate the global market for pharyngeal manometry testing.
The Asia Pacific is expected to witness the highest growth during the forecast period. High prevalence of gastro-intestinal motility diseases like dysphagia, increasing geriatric population, changing dietary habits and growing healthcare spending to dominate the global market for pharyngeal manometry testing in the Asia Pacific.
Leading pharyngeal manometry testing market manufacturers are currently using technologically advanced production techniques to improve product efficacy. The present growth prospects in the industry have also been investigated by looking at the continuing process development of top firms to analyse their market position and assist readers in formulating profitable partnership, expansion and collaboration strategies.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32912
Some of the leading manufacturers and suppliers of Pharyngeal Manometry Testing Market include,
- EB Neuro S.p.A.
- Medtronic PLC
- Boston Scientific Corporation
- Medspira
- PENTAX Medical
- CooperSurgical Inc.
- PENNINE HEALTHCARE
- Medica S.p.A.
- Panmed US
- RMS Medical Devices
- Dentsleeve International Ltd
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32912
Key Segments
By Product Type
- Conventional Manometry
- High-Resolution Manometry
- By Application
- Gastroesophageal Reflux Disease (GERD)
- Dysphagia
- Chest Pain
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Academic Research Institutes
- Others
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com